Dexmed/Buspirone Synergism on Shivering
Completed · Phase 4
Conditions studied: Hypothermia
In brief
The purpose of this research is to determine if the combination of buspirone and dexmedetomidine are effective as a treatment to induce therapeutic hypothermia. The design of the study includes four study days done in random order. The days are as follows: 1) Control (no drug); 2) Buspirone 60 mg orally; 3) Dexmedetomidine (delivered by a computer-controlled IV infusion to a target plasma concentration of 0.6 ng/ml); and, 3) the combination of buspirone 60 mg and dexmedetomidine (target plasma concentration of 0.6 ng/ml). a 20 cm-long catheter will be inserted into a cubital vein using standard aseptic technique In addition to the PIC line catheter, a simple peripheral catheter will be inserted into the other arm for drug administration. Throughout the study period, mean-skin temperature will be maintained at 31°C by adjusting the temperature of circulating water (Cincinnati Sub-Zero, Cincinnati, OH) and forced-air warmers (Augustine Medical, Inc., Eden Prairie, MN). Furthermore, the back, upper-body, and lower-body will individually be maintained at the designated skin temperature. Lactated Ringer's solution cooled to ≈3°C will be infused via the PIC-line at rates sufficient to decrease tympanic membrane temperature ≈1.5°C/h. Fluid will be administered as long as oxygen consumption or electromyographic intensity (see below) continues to increase or a total of 5 liters of fluid is given. Heart rate will be measured continuously using an electrocardiogram; blood pressure will be determined oscillometrically at 5 min intervals at the ankle. In case heart rate and/or blood pressure changes unexpectedly (by more than 30% of the baseline), the study will stop and the volunteer will be re-warmed immediately.
Key facts
- Study ID
- NCT00334360
- Run by
- The Cleveland Clinic
- People needed
- 8
- Starts
- 2004-09-01
- Expected to finish
- 2007-08-01
- Last updated by the study team
- 2016-06-29
Who can join
Age: 18 and older, up to 40. Sex: male. Healthy volunteers: accepted.
You may qualify if…
- 18-40 years
- normal weight (BMI <35)
- healthy
You may not qualify if…
- obese (BMI >35)
- taking any drugs
- thyroid disease, dysautonomia, or Raynaud's syndrome
- severe claustrophobia
Where it is running
- Outcomes Research Institute, University of Louisville — Louisville, Kentucky, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.